Receptor usage and pathogenicity of feline lentiviruses
Receptor usage and pathogenicity of feline lentiviruses
批准号:
7231978
负责人:
BRIAN J WILLETT
金额:
$12.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2009-03-31
关键词:
Acquired Immunodeficiency SyndromeAddressAffinityAffinity ChromatographyAnimal ModelAnimalsAntigensApoptoticB-LymphocytesBindingBinding SitesBiologicalBloodBreedingCD4 Positive T LymphocytesCXCR4 ReceptorsCXCR4 geneCell LineCell LineageCell physiologyCellsChimeric ProteinsClinicalDataDevelopmentDiagnosticDifferentiation AntigensDisease ProgressionEctopic ExpressionElderlyEmployee StrikesEpitopesFamily FelidaeFeline Immunodeficiency VirusFeline LentivirusesFelis catusFormalinFreezingFundingFutureGenesGeneticGreen Fluorescent ProteinsHIVHIV InfectionsHumanImmuneImmune systemImmunizationImmunoblottingImmunoglobulin GImmunologic Deficiency SyndromesIn VitroIncubatedInfectionLaboratoriesLeukocytesLigandsLuciferasesLymphoid CellMapsMeasuresMediatingMitogensMolecular CloningMonoclonal AntibodiesMononuclearMusMyeloid CellsNatureParentsPathogenesisPathogenicityPathway interactionsPatternPeripheral Blood Mononuclear CellPersonal CommunicationPhasePhenotypePilot ProjectsPlayPredispositionPrincipal InvestigatorProcessPropertyProteinsRangeReagentRecombinantsResistanceRoleSamplingSerologic testsSignal TransductionStaining methodStainsStudy of serumSubfamily lentivirinaeT-Cell DepletionT-LymphocyteTNF receptor-associated factor 2TRAF2 geneTestingTherapeuticThinkingThymus GlandTimeTissuesTranscriptional ActivationTropismUp-RegulationVaccinationVaccine DesignViralViral Load resultViral load measurementVirusVirus DiseasesVirus ReceptorsWorkcell typechemokine receptorenv Gene Productsenv Genesenv Glycoproteinsexpression vectorin vivolymph nodesmacrophagemonocytenovelnovel vaccinespolyclonal antibodyreceptorreceptor bindingresponsetransmission processvirus tropism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall aim of this project is to examine the role of the virus-receptor interaction in the pathogenesis of AIDS. The project will build upon our earlier work demonstrating that CXCR-4 and CD134 are the major co-receptor and primary binding receptor respectively for feline immunodeficiency virus (FIV), the lentivirus of the domestic cat. In the cat, FIV infection induces an immunodeficiency syndrome similar to AIDS in HIV-infected humans. In the proposed studies, we will ask whether receptor usage is a major determinant of FIV pathogenicity and whether viruses with distinct receptor usages are present during early and late infection.
In the previous funding period, we showed that primary strains of FIV require the co-expression of CD134 in addition to CXCR-4 in order to infect target cells. Aim 1 of this competing renewal will ask whether CD134-usage is ubiquitous amongst diverse isolates of FIV, examining the receptor usage of viruses from distinct geographical origins and genetic backgrounds.
Aim 2 will focus on the interaction between the viral envelope glycoprotein (Env) and CD134, mapping the viral binding site and asking whether Env binding perturbs the normal cellular function of CD134 in the expansion and survival of antigen-specific T cells. This section will address how the Env-CD134 interaction contributes to the pathogenesis of AIDS in the cat, of great significance to the interpretation of studies using FIV as an animal model for AIDS.
Finally, in Aim 3 we will investigate whether viruses with distinct biological phenotypes exist in early and late infection. Preliminary observations suggest that viruses derived from asymptomatic cats have distinct cell tropisms, receptor usages and biological properties in vivo compared to those derived from symptomatic cats. Moreover, as they achieve higher viral loads in vivo, and predominate in early infection, it is likely that these isolates are the ones that are transmitted in the field. As the majority of isolates studied to date have been derived from animals displaying clinical signs of infection, these studies are of profound importance to the selection of viruses for future trials of novel vaccines and therapeutics in this widely used small animal model of AIDS.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1126/science.1092124
发表时间:
2004-02-20
期刊:
SCIENCE
影响因子:
56.9
作者:
[Shimojima, M, Miyazawa, T, Willett, BJ]
通讯作者:
Willett, BJ
DOI:
10.1186/1742-4690-5-77
发表时间:
2008-08-22
期刊:
Retrovirology
影响因子:
3.3
作者:
[Willett BJ, McMonagle EL, Logan N, Samman A, Hosie MJ]
通讯作者:
Hosie MJ
Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand.
使用新型单克隆抗体 7D6 和 CD134 (Ox40) 配体探讨猫免疫缺陷病毒与 CD134 之间的相互作用。
DOI:
10.1128/jvi.01020-07
发表时间:
2007
期刊:
Journal of virology
影响因子:
5.4
作者:
[Willett,BrianJ, McMonagle,ElizabethL, Logan,Nicola, Spiller,OBrad, Schneider,Pascal, Hosie,MargaretJ]
通讯作者:
Hosie,MargaretJ
Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection.
CXCR4在猫外周血单核细胞上的表达:猫免疫缺陷病毒感染的影响。
DOI:
10.1128/jvi.77.1.709-712.2003
发表时间:
2003
期刊:
Journal of virology
影响因子:
5.4
作者:
[Willett,BrianJ, Cannon,CeliaA, Hosie,MargaretJ]
通讯作者:
Hosie,MargaretJ
Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus.
将 CD134 的结构域绘制为猫免疫缺陷病毒的功能受体。
DOI:
10.1128/jvi.00722-06
发表时间:
2006
期刊:
Journal of virology
影响因子:
5.4
作者:
[Willett,BrianJ, McMonagle,ElizabethL, Bonci,Francesca, Pistello,Mauro, Hosie,MargaretJ]
通讯作者:
Hosie,MargaretJ
共 12 条
Receptor usage and pathogenicity of feline lentiviruses
-
批准号:6944999
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2001
-
负责人:BRIAN J WILLETT
-
依托单位:
Receptor usage and pathogenicity of feline lentiviruses
-
批准号:6532866
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2001
-
负责人:BRIAN J WILLETT
-
依托单位:
Receptor usage and pathogenicity of feline lentiviruses
-
批准号:6607332
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2001
-
负责人:BRIAN J WILLETT
-
依托单位:
Receptor usage and pathogenicity of feline lentiviruses
-
批准号:6408921
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2001
-
负责人:BRIAN J WILLETT
-
依托单位:
Receptor usage and pathogenicity of feline lentiviruses
-
批准号:7036591
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2001
-
负责人:BRIAN J WILLETT
-
依托单位:
海外基金